Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Consonance Capital Management LP (CIK 1544773) reported $7.3M across 2 reported positions in its SEC 13F filing for 2022-09-30. Largest positions: SRZN ($7.1M, 97.05%), SRZNW ($215,000, 2.95%), CMPX ($0, 0.00%), GMED ($0, 0.00%), SLN ($0, 0.00%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | SRZN | SURROZEN INC | $7.1M | 97.05% | 3.5M | Hold |
| 2 | SRZNW | SURROZEN INC | $215,000 | 2.95% | 1.2M | Hold |
| 3 | CMPX | COMPASS THERAPEUTICS INC | $0 | 0.00% | 0 | Exited |
| 4 | GMED | GLOBUS MED INC | $0 | 0.00% | 0 | Exited |
| 5 | SLN | SILENCE THERAPEUTICS PLC | $0 | 0.00% | 0 | Exited |
| 6 | TNDM | TANDEM DIABETES CARE INC | $0 | 0.00% | 0 | Exited |
| 7 | UTHR | UNITED THERAPEUTICS CORP DEL | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2022-09-30